Cargando…
Clinical and Echocardiographic Parameters in Community-Based Individuals Symptomatic Post Pfizer and AstraZeneca COVID-19 Vaccination
Autores principales: | Chand, S., Wilcox, I., McGrady, M., Lal, S., Hunyor, I., O'Sullivan, J., Fulthorp, E., Price, M., Mccoll, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345547/ http://dx.doi.org/10.1016/j.hlc.2022.06.234 |
Ejemplares similares
-
Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021) -
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021) -
Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
por: Lukaszuk, Krzysztof, et al.
Publicado: (2022) -
Side Effects of COVID-19 Vaccines (Pfizer, AstraZeneca) in Saudi Arabia, Eastern Province
por: Ibrahim Amer, Fatma Hamza, et al.
Publicado: (2022)